Research in humans is a bit less impressive Clinical trials in humans A 1981 double-blind study found that chronic insomniac patients found that subjects slept 59% more, shorter sleep latency, and higher sleep efficiency (Schneider 1981) A 1987 double-blind study did not find any statistically significant changes in sleep structure as measured by REM sleep, NREM sleep, or total sleep time (Debellis 1987) A 1992 double-blind study in 14 chronic insomnia patients found higher sleep efficiency and subjectively estimated tiredness decreased to similar levels of healthy subjects in 7 nights of injections (Schneider 1992) There are some limitations to these studies however
Two samples were identified as markedly different from the remaining samples
Common symptoms include: Dry, itchy skin Hair thinning or excessive hair shedding Fatigue and weakness Numbness or tingling in hands and feet Difficulty concentrating or brain fog If left unaddressed, a deficiency can lead to more serious issues, such as anemia or neurological complications
Bacteriostatic water contains 0.9% benzyl alcohol, a preservative that prevents bacterial growth, making it suitable for multi-use vials
However, like all medications, GLP-1 drugs carry risks
Yes, most peptides come in powdered form and need to be reconstituted with a sterile solution before administration
